Daniel Egan

Proteomic characterisation of hADSCs undergoing osteodifferentiation

Buch

Bone related diseases and fractures are recognised as second to cancer in terms of overall disease footprint, with direct costs estimated to be in excess of $9 billion dollars per annum. Due to a lack of effective treatments available to repair bone, there has been a push towards regenerative medicine as a potential solution. Mesenchymal stem cells have been trialed in an attempt to regenerate bone, with their primary benefit elicited when they engraft and differentiate into functional osteoblasts. Due to the low efficiency at which they achieve this in vivo, differentiating the cells in vitro prior to implantation may elicit a more significa… Mehr

CHF 47.90

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

V105: Folgt in ca. 15 Arbeitstagen

Produktdetails

ISBN: 978-3-659-97458-8
EAN: 9783659974588
Produktnummer: 37560840
Verlag: LAP Lambert Academic Publishing
Sprache: Englisch
Erscheinungsjahr: 2016
Seitenangabe: 80 S.
Masse: H22.0 cm x B15.0 cm x D0.5 cm 137 g
Abbildungen: Paperback
Gewicht: 137

Über den Autor

Daniel Egan:MSc (Honours) - Biotechnology, received 2015 from the University of Technology, Sydney.BSc - Immunology, received 2013 from Macquarie University, Sydney.